First trial of concurrent amyloid and tau immunotherapies in sporadic Alzheimer’s is underway. Safety data are a go for subcutaneous remternetug. Plaque removal correlates with cognitive benefit in ...

Roche already has one Alzheimer’s candidate in its pipeline targeting tau, but has added a second via a deal with Belgian drugmaker UCB worth up to $2 billion. The Swiss pharma group is paying $ ...

Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for ...

A former Al Ahly star has accused the club’s departed manager of being a “star killer” who was responsible for the exits of Percy Tau and others. It’s no secret that Koller’s ...

Business Day TV speaks to Jordan Toy from Legacy Family Wealth ...

After permeabilization, cells were blocked with blocking buffer. Primary antibodies (goat anti-FOXA2 [1:200; R&D Systems AF2400] and rabbit anti-PAX6 [1:100; Biolegend 901301]) were applied for 1 h at ...